First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease,…
Phase 2 randomized controlled trial of a recombinant adenovirus type-5-vectored COVID-19 vaccine (Ad5-vectored COVID-19 vaccine) was conducted in China in April 2020 and involved more…
First review of all available evidence including 172 observational studies looking at how physical distancing, face masks, and eye protection affect the spread of COVID-19,…
Retraction: This article has been retracted by 3 of its 4 authors after they were unable to independently verify their data. A large observational study…
First evidence that early treatment with triple antiviral therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin — alongside standard care — is safe and shortens duration…